Skip directly to content

pharmakoresistene Epilepsie

cerbomed GmbH

Cerbomed is an innovative medical technology company that focuses on neuromodulation. The company, founded in 2005, focuses on transcutaneous Vagus Nerve Stimulation (t-VNS), which may offer an attractive therapy option for patients with hard-to-treat neurological and psychiatric illnesses. In 2010, cerbomed GmbH received the European authorisation (CE mark of conformity) for transcutaneous Vagus Nerve Stimulation (t-VNS) for indications epilepsy and depression. The therapy device NEMOSĀ® is available for treating cases of epilepsy in Germany and Austria.

Contact

Robert Pfeffer
Cerbomed GmbH